Biomarkers and clinical factors show statistical associations with sepsis-induced coagulopathy in 37,459 patients.
Your Blood May Signal a Deadly Clotting Crisis Before It Strikes
This systematic review and meta-analysis evaluated 37,459 patients to assess the association between various biomarkers and clinical factors…
Blood markers like glycocalyx degradation and low fibrinogen can predict deadly clotting in sepsis patients early, potentially saving lives …
Interim FDG PET predicts outcomes in large B-cell lymphoma, with DS 5 indicating highest risk.
Mid-Treatment Scan Predicts Lymphoma Outcomes Better Than Expected
A meta-analysis of 44 studies in large B-cell lymphoma patients found that interim FDG PET (iPET) had sensitivity of 0.78 and specificity of…
A PET scan halfway through lymphoma treatment predicts survival outcomes with striking accuracy, offering a powerful tool to personalize car…
Systematic review validates iPSC-derived organoids as models for ALS pathology compared to traditional 2D or animal models.
Scientists Grow Tiny ALS Brains in Labs — What It Could Mean
This systematic review evaluated in vitro organoid models derived from human-specific neural and neuromuscular subtypes for Amyotrophic Late…
For the first time, scientists can watch ALS unfold in human tissue grown outside the body — which could speed up the search for treatments …
Knowledge graph system for Jin San Zhen acupuncture therapy evaluation
Can AI Safely Guide a Centuries-Old Acupuncture Method?
This tool development and evaluation study assessed a knowledge graph and large language model hybrid system for Jin San Zhen acupuncture th…
Plain chatbots often invent facts about traditional medicine, but pairing one with a carefully built map of real studies cut the made-up ans…
Hyperbaric oxygen pretreatment in autologous HSCT patients shows trends toward improved survival and reduced organ damage.
Pressurized Oxygen Before a Transplant Shows Quiet Promise
This retrospective review examined 19 patients receiving hyperbaric oxygen (HBO) pretreatment versus 225 historical controls undergoing auto…
A pressurized oxygen treatment before transplant may reduce long-term organ damage, though only a couple of endpoints reached statistical si…
Recurrent low back pain accounts for disproportionate healthcare costs in Polish working-age adults
Why Your Back Pain Costs More Than the Pills
A 3-year observational cohort study of working-age adults in Poland found recurrent low back pain cases, comprising 24.5% of all LBP cases, …
Recurring low back pain eats up far more medical services per case than one-time flare-ups, mostly through repeated visits rather than expen…
Hetrombopag increases platelet counts in children with immune thrombocytopenia in phase 3 trial
A New Pill Helps Kids with a Rare Bleeding Disorder Avoid Crisis
A phase 3 randomized controlled trial in 88 children and adolescents with primary immune thrombocytopenia found hetrombopag significantly in…
For children with a stubborn immune bleeding disorder, a new oral medication offers a promising path to stable platelet levels and fewer tre…
Renizgamglogene autotemcel infusion showed engraftment and hemoglobin increases in severe sickle cell disease patients.
One Gene Edit Stopped Painful Sickle Cell Crises in Most Patients
This single-group, open-label, multicenter Phase 1-2 trial enrolled 28 patients with severe sickle cell disease aged 12 to 50 years. Followi…
A single infusion of CRISPR-edited stem cells eliminated painful sickle cell crises in 27 out of 28 patients by switching the body back to p…
Phase 2 trial compares Inotuzumab Ozogamicin plus R-CVP for DLBCL patients unfit for anthracycline
Can a new drug combination help lymphoma patients who can't take standard chemo?
A Phase 2 interventional trial enrolled 129 patients with diffuse large B-cell lymphoma (DLBCL) who were unsuitable for anthracycline-contai…
A new drug combo aims to treat aggressive lymphoma in older patients who can't take standard chemo due to heart risks.
Phase 2 trial finds mezagitamab increases platelet counts in adults with persistent or chronic ITP
Mezagitamab increased platelet counts in adults with chronic or persistent immune thrombocytopenia in this early trial.
A multicenter, double-blind, randomized, placebo-controlled Phase 2 trial in 41 adults with persistent or chronic ITP found 91% of participa…
Mezagitamab helped 91% of adults with chronic low platelet counts reach target levels, while only 23% on placebo did so in this early trial.
Meta-analysis compares CAR T-cell constructs in 1540 relapsed/refractory B-ALL patients
Which CAR T-cell therapy works best for relapsed leukemia?
A systematic review and meta-analysis of 40 clinical trials involving 1540 R/R B-ALL patients found pooled complete remission rates of 83.4%…
For relapsed leukemia, CAR T-cell therapies using 4-1BB components targeting CD19 achieved the highest remission rates with fewer side effec…
In children with Ph+ ALL, TKI-based therapy reduced HSCT use while maintaining comparable outcomes versus Ph+ALL04.
Reduced transplant use showed similar outcomes in children with Philadelphia chromosome-positive leukemia
This single-arm Phase 2 trial evaluated chemotherapy with tyrosine kinase inhibitors (TKIs) guided by minimal residual disease in 41 eligibl…
Children with a specific leukemia type achieved similar survival rates without stem cell transplants, offering a less intensive treatment op…